Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model (Q45407878)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 November 2006

Language	Label	Description	Also known as
English	Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model	scientific article published on 13 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

murine leukemia virus

object named as

murine leukemia virus

1 reference

based on heuristic

inferred from title

Jonathan L. Heeney

13

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

16

object named as

Britta Wahren

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Erik Rollman

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Nathalie Mathy

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Andreas Bråve

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Andreas Boberg

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Anne Kjerrström

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Cathy van Wely

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Gunnel Engström

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Susanne Johansson

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Kajsa Aperia

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Lars E Eriksson

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Reinhold Benthin

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Peter Ertl

12

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Gerald Voss

15

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

13 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2145-2154

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

DNA vaccines: progress and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

HIV vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Rational development of prophylactic HIV vaccines based on structural and regulatory proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Induction of HIV-1 specific mucosal immune responses by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

DNA-plasmids of HIV-1 induce systemic and mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

The search for the CD8+ cell anti-HIV factor (CAF).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Defining human immunodeficiency virus (HIV) type 1 immunotypes with six human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

Human immunodeficiency virus pseudotypes with expanded cellular and species tropism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.057

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.10.057

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45407878&oldid=2076665003"